BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31245858)

  • 1. Topical timolol maleate for treatment of tufted angioma.
    Zhang B; Zhang N; Wei L; Li L; Qiu L; Ma L
    J Dermatol; 2019 Nov; 46(11):e402-e403. PubMed ID: 31245858
    [No Abstract]   [Full Text] [Related]  

  • 2. Tufted angioma successfully treated with topical timolol gel-forming solution.
    Behera B; Remya R; Chandrashekar L; Thappa DM; Gochhait D
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):581-584. PubMed ID: 34219431
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
    Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
    Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical ophthalmic solution in infantile hemangioma.
    Jha AK; Mallik SK; Raihan M
    J Postgrad Med; 2012; 58(2):163-5. PubMed ID: 22718070
    [No Abstract]   [Full Text] [Related]  

  • 5. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
    Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile haemangioma: topical timolol gel may be safer in premature babies.
    Paul SP; Davis RF
    Br J Hosp Med (Lond); 2019 Aug; 80(8):i. PubMed ID: 31437034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Childhood haemangiomas treated with 1% timolol maleate cream].
    Kramer D; Cossio ML; Downey C
    Rev Chil Pediatr; 2016; 87(1):69-70. PubMed ID: 26455702
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
    Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
    Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing red scrotum syndrome (RSS) with topical timolol.
    Pyle TM; Heymann WR
    Int J Dermatol; 2019 Aug; 58(8):e162-e163. PubMed ID: 31034585
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical timolol gel for infantile hemangiomas: a pilot study.
    Pope E; Chakkittakandiyil A
    Arch Dermatol; 2010 May; 146(5):564-5. PubMed ID: 20479314
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas.
    Choo W
    Int J Pharm Compd; 2017; 21(4):282-289. PubMed ID: 28719370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.
    Chap S; Vu M; Robinson AJ; Braue A; Varigos GA; Scardamaglia L
    Australas J Dermatol; 2017 Aug; 58(3):242-243. PubMed ID: 28853153
    [No Abstract]   [Full Text] [Related]  

  • 14. Tufted angioma associated with Kasabach-Merritt phenomenon: a therapeutic challenge.
    Ferrandiz-Pulido C; Mollet J; Sabado C; Ferrer B; Garcia-Patos V
    Acta Derm Venereol; 2010 Sep; 90(5):535-7. PubMed ID: 20814640
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
    Tawfik AA; Alsharnoubi J
    Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
    Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
    Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episcleral infantile hemangioma successfully treated with topical timolol.
    Ciudad Blanco C; Campos Domínguez M; Moreno García B; Villanueva Álvarez-Santullano CA; Berenguer Fröhner B; Suárez Fernández R
    Dermatol Ther; 2015; 28(1):22-4. PubMed ID: 25286087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
    Almebayadh M
    J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
    Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
    Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.